SCHEMBL22888552

SCHEMBL22888552

c1ccc2c(-c3ccc(-c4nc(-c5ccc(-c6cccc7ccccc67)c6ccccc56)nc(-c5cccc6c5sc5ccccc56)n4)c4ccccc34)cccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.46
PARP14 Q460N5 1/20 0.43
GPR3 P46089 1/20 0.39
PRKDC P78527 6/20 0.39
MAPT P10636 3/20 0.39
PIK3CD O00329 2/20 0.39
PIK3CB P42338 2/20 0.39
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
HSD17B10 Q99714 3/20 0.36
TP53 P04637 2/20 0.36
MAPK1 P28482 2/20 0.36
ATM Q13315 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25050228 0.94 ALOX5 (0.46) ALOX5PARP14GPR3PRKDCMAPT
SCHEMBL22888852 0.94 ALOX5 (0.46) ALOX5PARP14GPR3PRKDCMAPT
SCHEMBL22888551 0.93 ALOX5 (0.44) ALOX5PARP14GPR3PRKDCMAPT
SCHEMBL21304467 0.92 ALOX5 (0.40) ALOX5PARP14GPR3PRKDCMAPT
SCHEMBL22888926 0.92 ALOX5 (0.43) ALOX5PARP14GPR3PRKDCMAPT
SCHEMBL22888800 0.92 ALOX5 (0.46) ALOX5PARP14GPR3PRKDCMAPT
SCHEMBL22889318 0.92 ALOX5 (0.43) ALOX5PARP14GPR3PRKDCMAPT
SCHEMBL21304836 0.91 ALOX5 (0.45) ALOX5PARP14PRKDCMAPTPIK3CD
SCHEMBL21304873 0.91 ALOX5 (0.45) ALOX5PARP14PRKDCMAPTPIK3CD
SCHEMBL21304620 0.91 ALOX5 (0.45) ALOX5PARP14PRKDCMAPTPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885PARP14 346/4885GPR3 273/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885PARP14 318/4885GPR3 231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.